Searched for
SANOFI INDIA SHARES
Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
- Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Buy Sanofi India, target price Rs 6200: Sharekhan by BNP ParibasSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13232.93 Crore) operating in Pharmaceuticals s...
- Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
- Buy Sanofi India, target price Rs 9250: Sharekhan by BNP ParibasSanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT a...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- Sanofi India Q3 results: Co posts net profit at Rs 530 croreSanofi India board in its meeting held on July 27 had approved a transaction for slump sale and transfer of its nutraceuticals business to ...
- Sanofi India Q2 results: Co reports net profit at Rs 178 croreRevenue from operations of the company stood at Rs 789.1 crore for the quarter under consideration. It was Rs 710.5 crore for the same peri...
- Add Sanofi India, target price Rs 7,680: CentrumRevenue growth excluding export for the domestic business continues to be at mid-high single digits.
- Add Sanofi Indiaa, target price Rs 7,973: ICICI SecuritiesICICI Securities expects Sanofi revenue/EBITDA/PAT to grow 5.2 per cent/ 9.0 per cent/13.3 per cent over CY20E- CY22E with declining export...
- Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
- Buy Sanofi India, target Rs 5510: Centrum BrokingBuy Sanofi India Ltd. at a price target of Rs 5510.
- Sanofi India Q4 net declines 58% to Rs 50.5 croreThe company had reported a net profit of Rs 120.2 crore in the same period a year ago, Sanofi India said in a BSE filing.
- Sanofi India Q4 net profit rises 30% to Rs 120.2 croreThe company had posted a net profit of Rs 92.5 crore for the corresponding period of the previous fiscal, Sanofi India said in a BSE filing.
- Sanofi India Q2 net dips 18.51 per cent at Rs 40.5 croreDrug firm Sanofi India today said its net profit dipped by 18.51 per cent to Rs 40.5 crore for the quarter ended June 30, 2012.
Load More
